These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33273485)
1. Assessment of a dried blood spot C-reactive protein method to identify disease flares in rheumatoid arthritis patients. D'Cruz LG; McEleney KG; Cochrane C; Tan KBC; Shukla P; Gardiner PV; Small D; Zhang SD; Gibson DS Sci Rep; 2020 Dec; 10(1):21089. PubMed ID: 33273485 [TBL] [Abstract][Full Text] [Related]
2. Validation of Biomarkers of CVD Risk from Dried Blood Spots in Community-Based Research: Methodologies and Study-Specific Serum Equivalencies. Samuelsson LB; Hall MH; McLean S; Porter JH; Berkman L; Marino M; Sembajwe G; McDade TW; Buxton OM Biodemography Soc Biol; 2015; 61(3):285-97. PubMed ID: 26652683 [TBL] [Abstract][Full Text] [Related]
3. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study. Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604 [TBL] [Abstract][Full Text] [Related]
4. Remote dried blood spot collection for inflammatory markers in older adults is feasible, reliable, and valid. Reed RG; Hillmann AR; Nation M; Braksator S; Sigler K Brain Behav Immun; 2024 Aug; 120():545-553. PubMed ID: 38971206 [TBL] [Abstract][Full Text] [Related]
5. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application. Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492 [TBL] [Abstract][Full Text] [Related]
6. Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information. Detrez I; Schops G; Lefrère J; Tops S; Van Assche G; Vermeire S; Van Moerkercke W; Ferrante M; Gils A AAPS J; 2018 Dec; 21(1):10. PubMed ID: 30564993 [TBL] [Abstract][Full Text] [Related]
7. Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling. Boons CCLM; Chahbouni A; Schimmel AM; Wilhelm AJ; den Hartog YM; Janssen JJWM; Hendrikse NH; Hugtenburg JG; Swart EL J Pharm Pharmacol; 2017 Oct; 69(10):1265-1274. PubMed ID: 28643375 [TBL] [Abstract][Full Text] [Related]
8. Flares in rheumatoid arthritis: do patient-reported swollen and tender joints match clinical and ultrasonography findings? Kuettel D; Terslev L; Weber U; Østergaard M; Primdahl J; Petersen R; Ammitzbøll-Danielsen M; Möller S; Hørslev-Petersen K Rheumatology (Oxford); 2020 Jan; 59(1):129-136. PubMed ID: 31382292 [TBL] [Abstract][Full Text] [Related]
9. Comparison of C-Reactive Protein in Dried Blood Spots and Saliva of Healthy Adolescents. Plank AC; Maschke J; Rohleder N; Fasching PA; Beckmann MW; Kornhuber J; Eichler A; Moll GH; Kratz O Front Immunol; 2021; 12():795580. PubMed ID: 34975902 [TBL] [Abstract][Full Text] [Related]
10. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205 [TBL] [Abstract][Full Text] [Related]
11. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis. Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698 [TBL] [Abstract][Full Text] [Related]
12. Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research. Brindle E; Fujita M; Shofer J; O'Connor KA J Immunol Methods; 2010 Oct; 362(1-2):112-20. PubMed ID: 20850446 [TBL] [Abstract][Full Text] [Related]
13. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole. Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155 [TBL] [Abstract][Full Text] [Related]
14. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial. Myasoedova E; Crowson CS; Giblon RE; McCarthy-Fruin K; Schaffer DE; Wright K; Matteson EL; Davis JM Clin Rheumatol; 2019 Nov; 38(11):3025-3032. PubMed ID: 31264032 [TBL] [Abstract][Full Text] [Related]
15. Agreement between the DAS28-CRP assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinic. Madsen OR J Rheumatol; 2013 Apr; 40(4):379-85. PubMed ID: 23457377 [TBL] [Abstract][Full Text] [Related]
16. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease. Jagannath B; Lin KC; Pali M; Sankhala D; Muthukumar S; Prasad S Inflamm Bowel Dis; 2020 Sep; 26(10):1533-1542. PubMed ID: 32720974 [TBL] [Abstract][Full Text] [Related]
17. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967 [TBL] [Abstract][Full Text] [Related]
18. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling. Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096 [TBL] [Abstract][Full Text] [Related]
19. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity. Holten K; Paulshus Sundlisæter N; Sexton J; Nordberg LB; Uhlig T; Kvien TK; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB; RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216290 [TBL] [Abstract][Full Text] [Related]
20. Classifying Self-Reported Rheumatoid Arthritis Flares Using Daily Patient-Generated Data From a Smartphone App: Exploratory Analysis Applying Machine Learning Approaches. Gandrup J; Selby DA; Dixon WG JMIR Form Res; 2024 May; 8():e50679. PubMed ID: 38743480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]